Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)—A Single Center, Retrospective Observational Study

Precision oncology and immunotherapy have revolutionized the treatment of advanced non-small-cell lung cancer (NSCLC). Emerging studies show that targeted therapies are also beneficial for patients with driver alterations such as epidermal growth factor receptor (EGFR) mutations in early-stage NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephan-Falkenau, Susann, Streubel, Anna, Mairinger, Thomas, Kollmeier, Jens, Misch, Daniel, Thiel, Sebastian, Bauer, Torsten, Pfannschmidt, Joachim, Hollmann, Manuel, Wessolly, Michael, Blum, Torsten Gerriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604339/
https://www.ncbi.nlm.nih.gov/pubmed/36293366
http://dx.doi.org/10.3390/ijms232012511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604339/
https://www.ncbi.nlm.nih.gov/pubmed/36293366
http://dx.doi.org/10.3390/ijms232012511

Ejemplares similares